Detection of Colorectal Disease by Stool Defensin Assay: An Exploratory Study

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 7, 2007, Pages 865-868

  Zou, Hongzhi ^a   Harrington, Jonathan J ^a   Sugumar, Aravind ^a   Klatt, Kristie K ^a   Smyrk, Thomas C ^a   Ahlquist, David A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; DEFENSIN; LACTOFERRIN; MESSENGER RNA;

ADENOMA; ARTICLE; CELL LINE; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTIVE SYSTEM CANCER; EPITHELIUM; FECES ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; MICRODISSECTION; NEOPLASM; NEUTROPHIL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-DEFENSINS; BIOLOGICAL MARKERS; CELLS, CULTURED; COLONIC DISEASES; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; RECTAL DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34447095116     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.03.013     Document Type: Article

References (27)

1. Uchida K., Matsuse R., Tomita S., et al. Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer. Clin Biochem 27 (1994) 259-264
2. Dubrow R., Kim C.S., and Eldred A.K. Fecal lysozyme: an unreliable marker for colorectal cancer. Am J Gastroenterol 87 (1992) 617-621
3. Limburg P.J., Ahlquist D.A., Gilbert J.A., et al. Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool. Dig Dis Sci 45 (2000) 494-499
4. Moran A., Robinson M., Lawson N., et al. Fecal alpha 1-antitrypsin detection of colorectal neoplasia: an evaluation using HemoQuant. Dig Dis Sci 40 (1995) 2522-2525
5. Limburg P.J., Devens M.E., Harrington J.J., et al. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. Am J Gastroenterol 98 (2003) 2299-2305
6. Osborn N.K., and Ahlquist D.A. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 128 (2005) 192-206
7. Melle C., Ernst G., Schimmel B., et al. Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology 129 (2005) 66-73
8. Cunliffe R.N., and Mahida Y.R. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J Leukoc Biol 75 (2004) 49-58
9. Cunliffe R.N. Alpha-defensins in the gastrointestinal tract. Mol Immunol 40 (2003) 463-467
10. Lundy F.T., Orr D.F., Gallagher J.R., et al. Identification and overexpression of human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue. Oral Oncol 40 (2004) 139-144
11. Albrethsen J., Bogebo R., Gammeltoft S., et al. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer 5 (2005) 8
12. Mizukawa N., Sugiyama K., Kamio M., et al. Immunohistochemical staining of human alpha-defensin-1 (HNP-1), in the submandibular glands of patients with oral carcinomas. Anticancer Res 20 (2000) 1125-1127
13. Mizukawa N., Sugiyama K., Yamachika E., et al. Presence of defensin in epithelial Langerhans cells adjacent to oral carcinomas and precancerous lesions. Anticancer Res 19 (1999) 2969-2971
14. Muller C.A., Markovic-Lipkovski J., Klatt T., et al. Human alpha-defensins HNPs-1, -2, and -3 in renal cell carcinoma: influences on tumor cell proliferation. Am J Pathol 160 (2002) 1311-1324
15. Zou H., Osborn N.K., Harrington J.J., et al. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 14 (2005) 830-834
16. Ahlquist D.A., McGill D.B., Schwartz S., et al. HemoQuant, a new quantitative assay for fecal hemoglobin: comparison with Hemoccult. Ann Intern Med 101 (1984) 297-302
17. Cunliffe R.N., Kamal M., Rose F.R., et al. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J Clin Pathol 55 (2002) 298-304
18. Sidransky D., Tokino T., Hamilton S.R., et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256 (1992) 102-105
19. Traverso G., Shuber A., Levin B., et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346 (2002) 311-320
20. Muller H.M., Oberwalder M., Fiegl H., et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening?. Lancet 363 (2004) 1283-1285
21. Ahlquist D.A., Skoletsky J.E., Boynton K.A., et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119 (2000) 1219-1227
22. Zou H., Harrington J.J., Klatt K.K., et al. A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 15 (2006) 1115-1119
23. Yamao T., Matsumura Y., Shimada Y., et al. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. Gastroenterology 114 (1998) 1196-1205
24. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med 328 (1993) 1365-1371
25. Kronborg O., Ugstad M., Fuglerud P., et al. Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 46 (2000) 795-800
26. Sugi K., Saitoh O., Hirata I., et al. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol 91 (1996) 927-934
27. Kayazawa M., Saitoh O., Kojima K., et al. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol 97 (2002) 360-369